2006Chinese Journal of Hospital PharmacyRequires access

Comparison of the pharmacokinetics between the two injections of nimodipine in beagle

Jiang Xin-guo

Open publisher page 0 citations

Abstract

OBJECTIVE To investigate the pharmacokinetics properties and bioequiavailence of two dosage forms of nimodipine(NM) in dogs.METHODS Single dose of NM was given to beagles in an open randomized cross-over design to study the pharmacokinetic parameters of NM.NM concentrations in plasma were determined by HPLC.RESULTS The pharmacokinetic parameters of NM emulsion for injection and injection were as follows: AUC_(0-5 h)((355.8)±(114.6)),((338.9)±(83.0)) h·μg·L~(-1),AUC_(0-∞)((356.8)±(114.5)),((339.9)±(82.9)) h·μg·L~(-1),t_(1/2α)((0.32)±(0.19)),((0.27)±(0.17)) h,t_(1/2β)((1.57)±(0.48)),((1.46)±(0.27)) h,respectively.The statistical analysis results showed that there was no significant difference between the two formulations.The relative bioavailability of the test formulation was((103.7)±(11.2))%.CONCLUSION The two formulations were bioequivalent and the emulsion for injection was superior to the injection in safety.

About this research paper

What this paper is about

OBJECTIVE To investigate the pharmacokinetics properties and bioequiavailence of two dosage forms of nimodipine(NM) in dogs.METHODS Single dose of NM was given to beagles in an open randomized cross-over design to study the pharmacokinetic parameters of NM.NM concentrations in plasma were determined by HPLC.RESULTS The pharmacokinetic parameters of NM emulsion for injection and injection were as follows: AUC_(0-5 h)((355.8)±(114.6)),((338.9)±(83.0)) h·μg·L~(-1),AUC_(0-∞)((356.8)±(114.5)),((339.9)±(82.9)) h·μg·L~(-1),t_(1/2α)((0.32)±(0.19)),((0.27)±(0.17)) h,t_(1/2β)((1.57)±(0.48)),((1.46)±(0.27)) h,respectively.The statistical analysis results showed that there was no significant difference between the two formulations.The relative bioavailability of the test formulation was((103.7)±(11.2))%.CONCLUSION The two formulations were bioequivalent and the emulsion for injection was superior to the injection in safety.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To investigate the pharmacokinetics properties and bioequiavailence of two dosage forms of nimodipine(NM) in dogs.METHODS Single dose of NM was given to beagles in an open randomized cross-over design to study the pharmacokinetic parameters of NM.NM concentrations in plasma were determined by HPLC.RESULTS The pharmacokinetic parameters of NM emulsion for injection and injection were as follows: AUC_(0-5 h)((355.8)±(114.6)),((338.9)±(83.0)) h·μg·L~(-1),AUC_(0-∞)((356.8)±(114.5)),((339.9)±(82.9)) h·μg·L~(-1),t_(1/2α)((0.32)±(0.19)),((0.27)±(0.17)) h,t_(1/2β)((1.57)±(0.48)),((1.46)±(0.27)) h,respectively.The statistical analysis results showed that there was no significant difference between the two formulations.The relative bioavailability of the test formulation was((103.7)±(11.2))%.CONCLUSION The two formulations were bioequivalent and the emulsion for injection was superior to the injection in safety.

Key concepts: Bioequivalence, Beagle, Pharmacokinetics, Nimodipine, Bioavailability, Chemistry, Pharmacology, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of the pharmacokinetics between the two injections of nimodipine in beagle — Research Paper | ScholarLens